Dubai Telegraph - Who should get paid for nature's sequenced genes?

EUR -
AED 3.822672
AFN 80.1383
ALL 99.756393
AMD 414.137764
ANG 1.874666
AOA 949.168589
ARS 1094.11536
AUD 1.673577
AWG 1.875962
AZN 1.773861
BAM 1.957644
BBD 2.100179
BDT 126.849507
BGN 1.952998
BHD 0.392226
BIF 3045.771018
BMD 1.040756
BND 1.405723
BOB 7.187772
BRL 6.112666
BSD 1.04018
BTN 90.074861
BWP 14.416543
BYN 3.403761
BYR 20398.808117
BZD 2.089368
CAD 1.508304
CDF 2969.27555
CHF 0.946187
CLF 0.037125
CLP 1024.384441
CNY 7.465968
CNH 7.573208
COP 4335.006914
CRC 527.802324
CUC 1.040756
CUP 27.580021
CVE 110.475858
CZK 25.131107
DJF 184.963108
DKK 7.461676
DOP 64.267159
DZD 140.542576
EGP 52.278282
ERN 15.611333
ETB 131.021161
FJD 2.41539
FKP 0.857153
GBP 0.837148
GEL 2.99702
GGP 0.857153
GHS 15.933899
GIP 0.857153
GMD 75.459997
GNF 9008.779273
GTQ 8.050585
GYD 218.155529
HKD 8.108745
HNL 26.646365
HRK 7.680305
HTG 136.032277
HUF 407.265351
IDR 16916.075895
ILS 3.728501
IMP 0.857153
INR 90.12053
IQD 1363.389726
IRR 43815.807022
ISK 145.965739
JEP 0.857153
JMD 164.096175
JOD 0.738204
JPY 160.578686
KES 134.774111
KGS 91.014096
KHR 4183.836721
KMF 492.121273
KPW 936.68008
KRW 1503.04844
KWD 0.320979
KYD 0.866817
KZT 539.578347
LAK 22636.431843
LBP 93251.693872
LKR 309.501588
LRD 204.509574
LSL 19.305879
LTL 3.07308
LVL 0.629543
LYD 5.109905
MAD 10.402866
MDL 19.357237
MGA 4881.143701
MKD 61.392307
MMK 3380.333319
MNT 3536.487356
MOP 8.347044
MRU 41.474351
MUR 48.280249
MVR 16.02206
MWK 1806.239447
MXN 21.559209
MYR 4.56896
MZN 66.502957
NAD 19.306337
NGN 1589.756105
NIO 38.278534
NOK 11.782284
NPR 144.119778
NZD 1.845311
OMR 0.400677
PAB 1.04018
PEN 3.864846
PGK 4.165623
PHP 60.718677
PKR 289.947797
PLN 4.204935
PYG 8211.736438
QAR 3.789651
RON 4.975231
RSD 117.111035
RUB 102.515963
RWF 1450.292812
SAR 3.903458
SBD 8.783372
SCR 14.848657
SDG 625.493982
SEK 11.492361
SGD 1.406352
SHP 0.857153
SLE 23.807259
SLL 21824.122713
SOS 594.80322
SRD 36.535762
STD 21541.537908
SVC 9.101837
SYP 13531.903206
SZL 19.306028
THB 34.982919
TJS 11.337891
TMT 3.642644
TND 3.317409
TOP 2.437553
TRY 37.230562
TTD 7.055715
TWD 34.197184
TZS 2646.983717
UAH 43.465302
UGX 3832.610778
USD 1.040756
UYU 45.133822
UZS 13509.006478
VES 60.254081
VND 26102.148345
VUV 123.560585
WST 2.914976
XAF 656.581887
XAG 0.032929
XAU 0.000372
XCD 2.812694
XDR 0.795092
XOF 655.158179
XPF 119.331742
YER 259.01801
ZAR 19.264223
ZMK 9368.048619
ZMW 29.07239
ZWL 335.122852
  • RBGPF

    2.7100

    64.91

    +4.18%

  • RYCEF

    0.0700

    7.45

    +0.94%

  • CMSD

    0.1600

    24.22

    +0.66%

  • RELX

    1.1100

    50.35

    +2.2%

  • CMSC

    0.0700

    23.68

    +0.3%

  • BCC

    2.3400

    128.66

    +1.82%

  • SCS

    0.0700

    11.64

    +0.6%

  • RIO

    1.1900

    60.91

    +1.95%

  • JRI

    -0.0200

    12.57

    -0.16%

  • NGG

    0.9700

    61.74

    +1.57%

  • VOD

    0.0600

    8.61

    +0.7%

  • BCE

    0.2000

    23.9

    +0.84%

  • BTI

    0.4200

    39.68

    +1.06%

  • GSK

    0.3000

    35.36

    +0.85%

  • AZN

    0.9900

    71.24

    +1.39%

  • BP

    0.4800

    31.61

    +1.52%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Sharma--DT